Nashville, Tennessee
1916 Patterson St #208, Nashville, TN 37203
Updated Jun 2026
Tennessee providers offer infusion therapy and Spravato across Nashville, Memphis, and Knoxville.
14 verified providers, mapped & reviewed.
Showing 14 of 14 clinics
Ranked by quality score (rating × review volume).
Nashville, Tennessee
1916 Patterson St #208, Nashville, TN 37203
Updated Jun 2026
Franklin, Tennessee
1909 Mallory Ln Suite 300, Franklin, TN 37067
Updated Jun 2026
Johnson City, Tennessee
106 Pinnacle Dr #107, Johnson City, TN 37615
Updated Jun 2026
Nashville, Tennessee
4414 Westlawn Dr, Nashville, TN 37209
Updated Jun 2026
Knoxville, Tennessee
10608 Flickenger Ln, Knoxville, TN 37922
Updated Jun 2026
Knoxville, Tennessee
601 S Concord St Ste 100, Knoxville, TN 37919
Updated Jun 2026
Franklin, Tennessee
480 Duke Dr #100, Franklin, TN 37067
Updated Jun 2026
Gallatin, Tennessee
1531 Hunt Club Blvd STE 106, Gallatin, TN 37066
Updated Jun 2026
Bartlett, Tennessee
5820 Stage Rd, Bartlett, TN 38134
Updated Jun 2026
Johnson City, Tennessee
2 Red Bush Ct, Johnson City, TN 37601
Updated Jun 2026
Tennessee Department of Health regulates ketamine clinics. BlueCross BlueShield of Tennessee and Cigna may cover Spravato when prior-authorization and REMS criteria are documented.
Our directory tracks 14 verified, Google-listed ketamine and Spravato providers across Tennessee, updated monthly from public business data.
Spravato (esketamine) is FDA-approved for treatment-resistant depression and is increasingly covered by major insurers in Tennessee when REMS protocol criteria are met. IV ketamine remains off-label and is rarely covered.
Most Tennessee clinics accept self-referral for IV ketamine, but Spravato typically requires a psychiatrist referral and documented treatment-resistant depression diagnosis.
IV infusions in Tennessee generally range $400–$800 per session, with most protocols calling for 6 initial sessions plus periodic boosters. Spravato copays vary by insurance plan.
IV ketamine (racemic) is delivered as an infusion in-clinic and used off-label for depression, PTSD, and chronic pain. Spravato (esketamine) is an FDA-approved intranasal spray for treatment-resistant depression and is covered by REMS — both must be administered in-clinic.